Mavacamten, a drug initially developed to treat hypertrophic cardiomyopathy, has shown signs of reducing heart stress in patients with heart failure with preserved ejection fraction. Heart failure ...

Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on ejection fraction reduction, myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term ...

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...

Heart failure (HF) substantially impacts the health and financial security of an increasing proportion of the US population. It worsens debility and quality of life and may lead to hospitalization and ...

My patients’ concerns about heart failure are usually, “What is my prognosis?” “What are the treatments, like medication and surgery, that are available to me?” But some people will ask me for their ...

Patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) commonly have improvements in their LVEF, but that doesn’t mean they can let their guard down, data from a large ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been established in ...

During embryonic development, the right ventricle is formed from the secondary heart field into a crescent-shaped, thin-walled structure. 6 It is the most anterior heart chamber, sitting just beneath ...

MRI-derived septal ECC is effective in detecting early cardiac dysfunction in DMD, surpassing traditional measures like LVEF. Cine DENSE MRI revealed reduced septal ECC in patients with DMD without ...

Please provide your email address to receive an email when new articles are posted on . Cardiac MRI demonstrated high diagnostic accuracy in patients with suspected cardiac tumor and may serve as a ...